Vigilare Wealth Management’s Zymeworks ZYME Stock Holding History
Bought
Maintained
Sold
Other funds holding ZYME
PA
EAM
CS
BBA
Vigilare Wealth Management's ZYME Position: Q4 2021 in Review
Vigilare Wealth Management sold out of Zymeworks (ZYME) in Q4 2021, closing a stake of 10,200 shares — an estimated $296K sold.
Vigilare Wealth Management first reported a position in ZYME in Q2 2020 and held it in 4 quarters. The position peaked at $296K in Q3 2021. 114 funds tracked by Wall St. Rank hold ZYME as of Q4 2021.
- Vigilare Wealth Management reported no remaining Zymeworks position as of Q4 2021 after selling out during the quarter.
- Vigilare Wealth Management sold 10,200 Zymeworks shares in Q4 2021, an estimated $296K.
- Vigilare Wealth Management first reported a position in Zymeworks in Q2 2020 and held it in 4 quarters.
- Vigilare Wealth Management's Zymeworks position peaked at $296K in Q3 2021.
- 114 funds tracked by Wall St. Rank held Zymeworks as of Q4 2021.
Based on Vigilare Wealth Management's 13F filing for Q4 2021, filed 7 Jan 2022.